Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
U16 Injection in Refractory/Recurrent B-cell Non-Hodgkin's Lymphoma
NCT05768529Phase 2Recruiting
- Sponsor
- Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd.
- Start
- Mar 2023
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of U16 in B-cell non-Hodgkin lymphoma, sponsored by Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd.. Started Mar 2023; status: recruiting.
02
Drugs
U16
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT05768529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05768529.